Literature DB >> 27896537

A serious misinterpretation of a consistent inverse association of statin use with glioma across 3 case-control studies.

Sander Greenland1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27896537     DOI： 10.1007/s10654-016-0205-z

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


× No keyword cloud information.
  4 in total

1.  Statin use and risk of glioma: population-based case-control analysis.

Authors:  Corinna Seliger; Christoph Rudolf Meier; Claudia Becker; Susan Sara Jick; Ulrich Bogdahn; Peter Hau; Michael Fred Leitzmann
Journal:  Eur J Epidemiol       Date:  2016-04-04       Impact factor: 8.082

2.  HMG CoA reductase inhibitors, NSAIDs and risk of glioma.

Authors:  Jennifer S Ferris; Lucie McCoy; Alfred I Neugut; Margaret Wrensch; Rose Lai
Journal:  Int J Cancer       Date:  2012-04-04       Impact factor: 7.396

3.  Use of statins and risk of glioma: a nationwide case-control study in Denmark.

Authors:  D Gaist; L Andersen; J Hallas; H Toft Sørensen; H D Schrøder; S Friis
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

4.  Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations.

Authors:  Sander Greenland; Stephen J Senn; Kenneth J Rothman; John B Carlin; Charles Poole; Steven N Goodman; Douglas G Altman
Journal:  Eur J Epidemiol       Date:  2016-05-21       Impact factor: 8.082
  4 in total
  9 in total

1.  Reply to Greenland: A serious misinterpretation of a consistent inverse association of statin use with glioma across 3 case-control studies.

Authors:  Corinna Seliger; Christoph R Meier; Claudia Becker; Susan S Jick; Ulrich Bogdahn; Peter Hau; Michael F Leitzmann
Journal:  Eur J Epidemiol       Date:  2016-11-28       Impact factor: 8.082

2.  For and Against Methodologies: Some Perspectives on Recent Causal and Statistical Inference Debates.

Authors:  Sander Greenland
Journal:  Eur J Epidemiol       Date:  2017-02-20       Impact factor: 8.082

Review 3.  Risk factors for childhood and adult primary brain tumors.

Authors:  Quinn T Ostrom; Maral Adel Fahmideh; David J Cote; Ivo S Muskens; Jeremy M Schraw; Michael E Scheurer; Melissa L Bondy
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300

4.  Statin use, hyperlipidemia, and risk of glioma.

Authors:  David J Cote; Bernard A Rosner; Stephanie A Smith-Warner; Kathleen M Egan; Meir J Stampfer
Journal:  Eur J Epidemiol       Date:  2019-09-26       Impact factor: 8.082

5.  Significance testing: Why does it prevail?

Authors:  Anders Ahlbom
Journal:  Eur J Epidemiol       Date:  2017-01-04       Impact factor: 8.082

6.  XGBoost algorithm and logistic regression to predict the postoperative 5-year outcome in patients with glioma.

Authors:  Zhiqiang Yan; Jiang Wang; Qiufeng Dong; Lian Zhu; Wei Lin; Xiaofan Jiang
Journal:  Ann Transl Med       Date:  2022-08

Review 7.  Semantic and cognitive tools to aid statistical science: replace confidence and significance by compatibility and surprise.

Authors:  Zad Rafi; Sander Greenland
Journal:  BMC Med Res Methodol       Date:  2020-09-30       Impact factor: 4.615

8.  Predicting factors of tumor progression in adult patients with low-grade glioma within five years after surgery.

Authors:  Xuezheng Li; Ruimin Li; Hongbo Ren; He Liu; Hongfeng Liu
Journal:  Transl Cancer Res       Date:  2021-04       Impact factor: 1.241

9.  The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter Study.

Authors:  Pranay Sinha; S Reza Jafarzadeh; Sabrina A Assoumou; Catherine G Bielick; Bethanne Carpenter; Shivani Garg; Sahni Harleen; Tuhina Neogi; Midori Jane Nishio; Manish Sagar; Veronika Sharp; Eugene Y Kissin
Journal:  J Infect Dis       Date:  2021-02-24       Impact factor: 7.759
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.